Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Dow
Argus Health
Cerilliant
Mallinckrodt
Chubb
McKesson
UBS

Generated: August 21, 2018

DrugPatentWatch Database Preview

BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for betamethasone acetate; betamethasone sodium phosphate and what is the scope of betamethasone acetate; betamethasone sodium phosphate freedom to operate?

Betamethasone acetate; betamethasone sodium phosphate is the generic ingredient in two branded drugs marketed by Luitpold and Merck Sharp Dohme, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for betamethasone acetate; betamethasone sodium phosphate. Six suppliers are listed for this compound.

Summary for BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
Pharmacology for BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE

US Patents and Regulatory Information for BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE betamethasone acetate; betamethasone sodium phosphate INJECTABLE;INJECTION 090747-001 Jul 31, 2009 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme CELESTONE SOLUSPAN betamethasone acetate; betamethasone sodium phosphate INJECTABLE;INJECTION 014602-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme CELESTONE SOLUSPAN betamethasone acetate; betamethasone sodium phosphate INJECTABLE;INJECTION 014602-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Merck
Boehringer Ingelheim
Dow
Cipla
QuintilesIMS
Express Scripts
Mallinckrodt
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.